Oncological outcomes from trimodality therapy receiving definitive doses of neoadjuvant chemoradiation (≥60 Gy) and factors influencing consideration for surgery in stage III non-small cell lung cancer
Sign Up to like & getrecommendations! Published in 2017 at "Advances in Radiation Oncology"
DOI: 10.1016/j.adro.2017.07.009
Abstract: Purpose Guidelines for locally advanced non-small cell lung cancer (LA-NSCLC) recommend definitive chemoradiation therapy (CRT) for cN2-N3 disease, reserving surgery for patients with minimal nodal involvement at presentation. The current literature suggests that surgery after… read more here.
Keywords: trimodality therapy; surgery; stage iii; definitive doses ... See more keywords